Effect of ivermectin vs placebo on time to sustained recovery in outpatients with mild to moderate COVID-19: a randomized clinical trial

S Naggie, DR Boulware, CJ Lindsell, TG Stewart… - Jama, 2022 - jamanetwork.com
Importance The effectiveness of ivermectin to shorten symptom duration or prevent
hospitalization among outpatients in the US with mild to moderate symptomatic COVID-19 is …
被引用次数：67 相关文章

Effect of ivermectin vs placebo on time to sustained recovery in outpatients with mild to moderate COVID-19: a randomized clinical trial.

S Naggie, DR Boulware, CJ Lindsell, TG Stewart… - 2022 - cabidigitallibrary.org
Importance: The effectiveness of ivermectin to shorten symptom duration or prevent
hospitalization among outpatients in the US with mild to moderate symptomatic COVID-19 is …

Effect of Ivermectin vs Placebo on Time to Sustained Recovery in Outpatients With Mild to Moderate COVID-19: A Randomized Clinical Trial

S Naggie, DR Boulware, CJ Lindsell… - JAMA: the journal of …, 2022 - scholarship.miami.edu
Abstract Adult Ambulatory Care Anti-Infective Agents-adverse effects Anti-Infective Agents-
therapeutic use COVID-19-mortality COVID-19-prevention & control COVID-19 Drug …

Effect of Ivermectin vs Placebo on Time to Sustained Recovery in Outpatients With Mild to Moderate COVID-19: A Randomized Clinical Trial

S Naggie, DR Boulware, CJ Lindsell, TG Stewart… - 2022 - pubmed.ncbi.nlm.nih.gov
Importance The effectiveness of ivermectin to shorten symptom duration or prevent
hospitalization among outpatients in the US with mild to moderate symptomatic COVID-19 is …

Effect of Ivermectin vs Placebo on Time to Sustained Recovery in Outpatients With Mild to Moderate COVID-19: A Randomized Clinical Trial.

S Naggie, DR Boulware, CJ Lindsell… - JAMA: Journal of …, 2022 - search.ebscohost.com
Abstract < bold> Importance: </bold> The effectiveness of ivermectin to shorten
symptom duration or prevent hospitalization among outpatients in the US with mild to …

Effect of Ivermectin vs Placebo on Time to Sustained Recovery in Outpatients with Mild to Moderate COVID-19: A Randomized Clinical Trial

S Naggie, DR Boulware, CJ Lindsell, TG Stewart… - JAMA, 2022 - pure.johnshopkins.edu
Importance: The effectiveness of ivermectin to shorten symptom duration or prevent
hospitalization among outpatients in the US with mild to moderate symptomatic COVID-19 is …
[HTML] nih.gov

[HTML][HTML] Effect of Ivermectin vs Placebo on Time to Sustained Recovery in Outpatients With Mild to Moderate COVID-19: A Randomized Clinical Trial

S Naggie, DR Boulware, CJ Lindsell, TG Stewart… - JAMA, 2022 - ncbi.nlm.nih.gov
Effect of Ivermectin vs Placebo on Time to Sustained Recovery in Outpatients With Mild to
Moderate COVID-19 - PMC Back to Top Skip to main content NIH NLM Logo Access keys NCBI …

Effect of Ivermectin vs Placebo on Time to Sustained Recovery in Outpatients with Mild to Moderate COVID-19: A Randomized Clinical Trial

S Naggie, DR Boulware, CJ Lindsell, TG Stewart… - JAMA, 2022 - experts.umn.edu
Importance: The effectiveness of ivermectin to shorten symptom duration or prevent
hospitalization among outpatients in the US with mild to moderate symptomatic COVID-19 is …

Effect of Ivermectin vs Placebo on Time to Sustained Recovery in Outpatients With Mild to Moderate COVID-19: A Randomized Clinical Trial.

S Naggie, DR Boulware, CJ Lindsell, TG Stewart… - JAMA, 2022 - europepmc.org
Effect of Ivermectin vs Placebo on Time to Sustained Recovery in Outpatients With Mild to
Moderate COVID-19: A Randomized Clinical Trial. - Abstract - Europe PMC Sign in | Create …

Effect of Ivermectin vs Placebo on Time to Sustained Recovery in Outpatients With Mild to Moderate COVID-19: A Randomized Clinical Trial.

S Naggie, DR Boulware, CJ Lindsell, TG Stewart… - JAMA, 2022 - europepmc.org
Effect of Ivermectin vs Placebo on Time to Sustained Recovery in Outpatients With Mild to
Moderate COVID-19: A Randomized Clinical Trial. - Abstract - Europe PMC Sign in | Create …